Functional studies in murine corticotroph tumor cells demonstrated that GPR162 negatively regulates P OMC mRNA expression and the GPR162 variant R218* that we had demonstrated in our index patient also resulted in reduced corticotroph tumor POMC mRNA expression. This evidence concerns the gene GPR162 and neoplasm.